Biotech company pushes development of hydrogel-based wound product

10/8/2013 | PharmaBiz.com (India)

Biotechnology company BioTime has begun pre-approval testing of a wound dressing based on cross-linked thiol-modified hyaluronan and thiol-modified gelatin. The product maintains a moist wound bed, and a biodegradable matrix serves as a scaffold for cellular infiltration and capillary growth. If approved, the product may provide a foundation for bioactive wound care products that deliver biological factors or cells.

View Full Article in:

PharmaBiz.com (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Associate Manager, Regulatory Affairs
Stryker
Mahwah, NJ
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC